Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark V Sherrid

Showing results (21-30 of 133) with videos related to

Pageof 14
Sort By:
Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology|December 13, 2006
Pathophysiology of hypertrophic cardiomyopathy determines its medical treatmentDan Musat, Mark V Sherrid
Journal of the American College of Cardiology|November 6, 2020
The Mitral Valve in Hypertrophic Cardiomyopathy: Other Side of the Outflow TractMark V Sherrid, David H Adams
Chest|May 8, 2008
Oral disopyramide for the acute treatment of severe outflow obstruction in hypertrophic cardiomyopathy in the ICU settingTseday E Sirak, Mark V Sherrid
Annals of Cardiothoracic Surgery|September 26, 2017
The surgical management of obstructive hypertrophic cardiomyopathy: the RPR procedure-resection, plication, releaseDaniel G Swistel, Mark V Sherrid
Progress in Cardiovascular Diseases|November 26, 2008
Risks and challenges of implantable cardioverter-defibrillators in young adultsMark V Sherrid, James P Daubert
Journal of the American College of Cardiology|December 20, 2014
Thin-filament mutations, hypertrophic cardiomyopathy, and riskMark V Sherrid, Milla Arabadjian, Anna Koulova
European Heart Journal. Case Reports|January 15, 2026
Letter to the editor concerning: Catastrophic apical ballooning in obstructive hypertrophic cardiomyopathy patient treated with mavacamtenMark V Sherrid, Bette Kim, Daniele Massera
Circulation. Cardiovascular Interventions|April 19, 2019
Letter by Sherrid et al Regarding Article, "Bail-Out Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy in a Patient With Takotsubo Cardiomyopathy-Induced Cardiogenic Shock"Mark V Sherrid, Louai Razzouk, Daniele Massera
Frontiers in Pediatrics|October 18, 2021
Availability and Utilization of Automated External Defibrillators in New York State SchoolsMilla Arabadjian, Stephanie Serrato, Mark V Sherrid
Progress in Cardiovascular Diseases|June 13, 2012
Can pharmacologic gradient reduction decrease mortality in hypertrophic cardiomyopathy?Dan Musat, Silviana Marineci, Mark V Sherrid
Pageof 14

Showing results (21-30 of 133) with videos related to

Sort By:
Pageof 14
Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology|December 13, 2006
Pathophysiology of hypertrophic cardiomyopathy determines its medical treatmentDan Musat, Mark V Sherrid
Journal of the American College of Cardiology|November 6, 2020
The Mitral Valve in Hypertrophic Cardiomyopathy: Other Side of the Outflow TractMark V Sherrid, David H Adams
Chest|May 8, 2008
Oral disopyramide for the acute treatment of severe outflow obstruction in hypertrophic cardiomyopathy in the ICU settingTseday E Sirak, Mark V Sherrid
Annals of Cardiothoracic Surgery|September 26, 2017
The surgical management of obstructive hypertrophic cardiomyopathy: the RPR procedure-resection, plication, releaseDaniel G Swistel, Mark V Sherrid
Progress in Cardiovascular Diseases|November 26, 2008
Risks and challenges of implantable cardioverter-defibrillators in young adultsMark V Sherrid, James P Daubert
Journal of the American College of Cardiology|December 20, 2014
Thin-filament mutations, hypertrophic cardiomyopathy, and riskMark V Sherrid, Milla Arabadjian, Anna Koulova
European Heart Journal. Case Reports|January 15, 2026
Letter to the editor concerning: Catastrophic apical ballooning in obstructive hypertrophic cardiomyopathy patient treated with mavacamtenMark V Sherrid, Bette Kim, Daniele Massera
Circulation. Cardiovascular Interventions|April 19, 2019
Letter by Sherrid et al Regarding Article, "Bail-Out Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy in a Patient With Takotsubo Cardiomyopathy-Induced Cardiogenic Shock"Mark V Sherrid, Louai Razzouk, Daniele Massera
Frontiers in Pediatrics|October 18, 2021
Availability and Utilization of Automated External Defibrillators in New York State SchoolsMilla Arabadjian, Stephanie Serrato, Mark V Sherrid
Progress in Cardiovascular Diseases|June 13, 2012
Can pharmacologic gradient reduction decrease mortality in hypertrophic cardiomyopathy?Dan Musat, Silviana Marineci, Mark V Sherrid
Pageof 14